2025 fourth_quarter Filing
RRFiled
January 5, 2026
Lobbying Activities
Health IssuesView all
Rare disease policy, drug approval process
Lobbyists (2)
ms PATRICIA LOUISE DELOATCHE
Health Policy Director, Sen. Orrin Hatch; Chief of Staff,Legislative Director, Legislative Assistant, Rep. MikeBilirakis
NewABIGAIL CARROLL
Detailee to the Energy and Commerce Committee, U.S. House of Representatives
New